EichorEICHOR
Location: Billings Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Billings

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Intermountain Health St. Vincent Regional Hospital - Cancer · Merck Sharp & Dohme LLC · NCT06136559MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Billings Clinic Cancer Center · National Cancer Institute (NCI) · NCT05564390Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Billings Clinic Cancer Center · NRG Oncology · NCT05624996Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Billings Clinic Cancer Center · Alliance for Clinical Trials in Oncology · NCT07321652Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Billings Clinic Cancer Center · Alliance for Clinical Trials in Oncology · NCT07091617A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Intermountain Health St. Vincent Regional Hospital - Cancer · Pfizer · NCT07144280A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · St. Vincent Frontier Cancer Center · Loxo Oncology, Inc. · NCT05254743A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · St. Vincent Frontier Cancer Center ( Site 0043) · Merck Sharp & Dohme LLC · NCT06077760Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Billings Clinic Cancer Center · SWOG Cancer Research Network · NCT06769126Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Billings Clinic Cancer Center · NRG Oncology · NCT05946213Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stag
Phase 2 · Intermountain Health St. Vincent Regional Hospital - Cancer · Merck Sharp & Dohme LLC · NCT06797635Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Billings Clinic Cancer Center · NRG Oncology · NCT05174169Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Billings Clinic Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632327Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Billings Clinic Cancer Center · Alliance for Clinical Trials in Oncology · NCT06931340A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Intermountain Health St Vincent Regional Hospital - Cancer C · AbbVie · NCT04928846ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Billings Clinic Cancer Center · Alliance for Clinical Trials in Oncology · NCT06876714Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · Billings Clinic Cancer Center · Canadian Cancer Trials Group · NCT03550391Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Billings Clinic Cancer Center · National Cancer Institute (NCI) · NCT04269902Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Billings Clinic Cancer Center · Canadian Cancer Trials Group · NCT06592924A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Billings Clinic /ID# 258316 · AbbVie · NCT06345339Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Billings Clinic Cancer Center · SWOG Cancer Research Network · NCT05806515Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress
Phase 2 · Billings Clinic Cancer Center · National Cancer Institute (NCI) · NCT06649812Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Billings Clinic Cancer Center · NRG Oncology · NCT03180268A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · Billings Clinic ( Site 3255) · Merck Sharp & Dohme LLC · NCT07513376SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · Massive Bio SYNERGY-AI site · Massive Bio, Inc. · NCT03452774Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Phase 2 · Billings Clinic Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632977Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Billings Clinic Cancer Center · Alliance for Clinical Trials in Oncology · NCT04242095Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Billings Clinic Cancer Center · National Cancer Institute (NCI) · NCT05256225Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Billings Clinic Cancer Center · National Cancer Institute (NCI) · NCT05554393
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.